Home/Filings/4/0001231977-12-000071
4//SEC Filing

Coissac Patrice 4

Accession 0001231977-12-000071

CIK 0000899866other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 4:42 PM ET

Size

17.8 KB

Accession

0001231977-12-000071

Insider Transaction Report

Form 4
Period: 2012-08-27
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
  • Exercise/Conversion

    Option to Purchase Common Stock

    2012-08-2712,19877,802 total
    Exercise: $42.66From: 2011-05-02Exp: 2021-02-02Common Stock, par value $.0001 per share (12,198 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2012-08-2821,55156,251 total
    Exercise: $42.66From: 2011-05-02Exp: 2021-02-02Common Stock, par value $.0001 per share (21,551 underlying)
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2012-08-27$42.66/sh+12,198$520,367127,814 total
  • Sale

    Common Stock, par value $.0001 per share

    2012-08-27$107.05/sh41,932$4,488,82185,882 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2012-08-28$42.66/sh+21,551$919,366107,433 total
  • Sale

    Common Stock, par value $.0001 per share

    2012-08-28$106.37/sh21,551$2,292,38085,882 total
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2012-08-27$22.90/sh+29,734$680,909115,616 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2012-08-2729,73437,500 total
    Exercise: $22.90From: 2010-04-28Exp: 2020-01-28Common Stock, par value $.0001 per share (29,734 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $107.00 - $107.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $106.00 - $106.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeother

Related Parties

1
  • filerCIK 0001341212

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:42 PM ET
Size
17.8 KB